Blood · 2009 · 171 citations · 36 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunoregulationSignal TransductionDendritic Cell BiologyDendritic Cell RegulationImmune Cell SignalingInterferon ResponsesRegulatory T CellsT Cell BiologyDendritic Cell-mediated T Cell ActivationDendritic Cell-t Cell InteractionIndoleamine 2, 3-Dioxygenase PathwayInterferon Gamma ProductionInterferon Gamma ResponseInterferon-gamma ResponsesRegulatory T Cell Induction By Dendritic Cells
The role of the tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase (IDO) in down-regulating human alloresponses has recently been controversially debated. We here demonstrate that human monocyte-derived dendritic cells (mDCs) can be endowed with sustained IDO competence in vitro by 48-hour activation with lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma). IFN-gamma also amplified proinflammatory cytokine secretion during activation. Yet, on reculture after activation cytokine production ceased, whereas IDO enzymatic activity continued. Manipulation of tryptophan metabolism did not affect proinflammatory cytokine release, suggesting that IFN-gamma triggers IDO activity and proinflammatory cytokine release as distinct cellular programs. IDO-competent DCs down-regulated allogeneic T-cell responses, but this IDO-mediated effect was overcome by slightly modifying cell culture conditions. Nevertheless, the CD4(+)CD25(+) T-cell fraction stimulated by IDO-competent DCs displayed substantial suppressor activity. This suppressive activity (1) required allogeneic stimulation for its induction, (2) affected third-party T cells, and (3) was reduced by the IDO inhibitor methyl-thiohydantoin-tryptophan. It became also manifest when DC/T-cell cocultures were initiated with naive (CD4(+)CD25(-)CD45RA(+)) T cells, indicating the differentiation of adaptive regulatory T cells. Together, these findings suggest that IFN-gamma triggered IDO competence in human mDCs constitutes a critical factor for endowing allogeneic T cells with regulatory activity.
36
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
David H. Munn, Min Zhou, John T. Attwood et al. · Science · 1998 · 2.6K citations
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
David H. Munn, Ebrahim Shafizadeh, John T. Attwood et al. · The Journal of Experimental Medicine · 1999 · 1.6K citations · Full text